retatrutide triple agonist phase 2 nejm 2023 obesity results in adults with over 104 weeks in the highest dose group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 Retatrutide study sees significant weight

The Recovery Peptide BPC-157 Clinically studied peptide found to assist with recovery, promote a healthy inflammatory response, and strengthen the gut.* Supports muscle, tendon & soft tissue recovery* Helps maintain gut lining integrity* Nourishes resilience at the cellular level* Shop BPC-157 Functional Recovery TB4-Frag A synthetic fragment of the Thymosin Beta-4 protein, often paired with BPC-157 for its recovery benefits.* Supports joint & muscle health* Promotes cardiovascular health* Balances inflammatory response* Shop TB4-Frag (/parn/

Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, hman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF

L.BosnjakE.HolmL.FrystykJ.et al (2012)

They can assess your health status, listen to your objectives, and tailor a dosage that aligns with your wellness journey

Individual Variation: Effects varied among participants within trials